27.73
前日終値:
$26.98
開ける:
$27.11
24時間の取引高:
789.87K
Relative Volume:
1.16
時価総額:
$2.06B
収益:
$105.97M
当期純損益:
$-81.13M
株価収益率:
-25.70
EPS:
-1.0791
ネットキャッシュフロー:
$-35.43M
1週間 パフォーマンス:
+3.82%
1か月 パフォーマンス:
+21.20%
6か月 パフォーマンス:
+48.93%
1年 パフォーマンス:
+153.47%
Zymeworks Inc. Stock (ZYME) Company Profile
名前
Zymeworks Inc.
セクター
電話
604-678-1388
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
Compare ZYME vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ZYME
Zymeworks Inc.
|
27.73 | 2.00B | 105.97M | -81.13M | -35.43M | -1.0791 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-12-03 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-10-24 | 再開されました | Wells Fargo | Equal Weight |
| 2025-10-14 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-10-10 | 開始されました | B. Riley Securities | Buy |
| 2025-05-20 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-11-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | 再開されました | Wells Fargo | Overweight |
| 2023-01-04 | 繰り返されました | H.C. Wainwright | Neutral |
| 2022-12-20 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | 再開されました | Wells Fargo | Overweight |
| 2022-05-05 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-03-15 | 開始されました | Evercore ISI | Outperform |
| 2021-12-10 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | 再開されました | Guggenheim | Neutral |
| 2021-10-07 | 開始されました | Jefferies | Hold |
| 2021-03-31 | 開始されました | Credit Suisse | Outperform |
| 2021-02-25 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | 再開されました | H.C. Wainwright | Buy |
| 2021-01-25 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-09-29 | 再開されました | JP Morgan | Neutral |
| 2020-08-06 | 開始されました | SVB Leerink | Outperform |
| 2020-01-10 | 開始されました | Wolfe Research | Outperform |
| 2019-12-09 | 開始されました | JP Morgan | Neutral |
| 2019-11-25 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-20 | 開始されました | Guggenheim | Buy |
| 2019-09-30 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | 開始されました | Stifel | Buy |
| 2019-07-18 | 開始されました | Deutsche Bank | Buy |
| 2018-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2018-03-19 | 開始されました | Raymond James | Outperform |
すべてを表示
Zymeworks Inc. (ZYME) 最新ニュース
Perceptive-linked holders report 3.97M shares of Zymeworks (ZYME) - Stock Titan
Zymeworks Inc stock (US98986T1088): Why its biopharma pipeline strategy is suddenly worth a closer l - AD HOC NEWS
Zymeworks (ZYME) price target increased by 12.53% to 40.88 - MSN
Zymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call Transcript - MSN
How Investors Are Reacting To Zymeworks (ZYME) Elevating EcoR1 Veterans To Key Executive Roles - simplywall.st
Zymeworks Inc stock (US98986T1088): Why its biopharma pipeline is suddenly worth a closer look - AD HOC NEWS
HC Wainwright & Co. Upgrades Zymeworks (ZYME) - MSN
JPMorgan Chase & Co. Cuts Stock Position in Zymeworks Inc. $ZYME - MarketBeat
ZYME SEC FilingsZymeworks 10-K, 10-Q, 8-K Forms - Stock Titan
Zymeworks (NASDAQ: ZYME) awards options, RSUs and PSUs to officer - Stock Titan
Zymeworks (NASDAQ: ZYME) awards options, RSUs and PSUs to EVP - Stock Titan
Zymeworks (ZYME) executive reports significant option and RSU awards - Stock Titan
Zymeworks (ZYME) EVP holds 167,000 options and 111,111 RSUs - Stock Titan
Zymeworks names Schayowitz as R&D head, Platshon as CBO By Investing.com - Investing.com Australia
Investment Recap: Should I average down on Zymeworks Inc stock2026 Sector Moves & Verified Momentum Watchlists - baoquankhu1.vn
Zymeworks Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth - wahanariau.com
Zymeworks Bolsters Executive Team to Drive Next Phase of Growth - TipRanks
Zymeworks names Schayowitz as R&D head, Platshon as CBO - Investing.com
Zymeworks Inc. Appoints Adam Schayowitz as Head of R&D and Scott Platshon as Chief Business Officer, Effective April 9, 2026 - marketscreener.com
Buybacks Report: Will Zymeworks Inc benefit from geopolitical trends2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Why Zymeworks (ZYME) Is Up 6.7% After FDA Fast Track Win And CFO Appointment - Sahm
Zymeworks (NASDAQ: ZYME) grants CFO large option and RSU awards - Stock Titan
Zymeworks (NASDAQ: ZYME) CFO reports zero beneficial share ownership - Stock Titan
Short Squeeze: Will Zymeworks Inc benefit from rising consumer demand2026 Macro Moves & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Capricorn Fund Managers Ltd Buys Shares of 1,022,840 Zymeworks Inc. $ZYME - MarketBeat
A Look At Zymeworks (ZYME) Valuation After Fast Track Win And New CFO Appointment - Sahm
ZYME PE Ratio & Valuation, Is ZYME Overvalued - Intellectia AI
ZYME Technical Analysis & Stock Price Forecast - Intellectia AI
Zymeworks Inc. R (ZA8.DU) Q1 FY2025 earnings call transcript - Yahoo Finance
Zymeworks Inc. (ZYME) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q3 2025 Zymeworks Inc Earnings Call Transcript - GuruFocus
Trade Report: How sensitive is Zymeworks Inc to inflationMarket Rally & Capital Efficiency Focused Ideas - baoquankhu1.vn
ZymeworksLeveraging Partnerships For Value - RTTNews
Zymeworks appoints Kristin Stafford as chief financial officer By Investing.com - Investing.com South Africa
Zymeworks Inc. (ZYME) stock price, news, quote and history - Yahoo Finance Singapore
Trade Recap: Can Zymeworks Inc grow without dilution2026 Movers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Zymeworks appoints Kristin Stafford as CFO - MSN
Zymeworks Inc. Announces Executive Changes, Effective from April 1, 2026 - marketscreener.com
Zymeworks Appoints Kristin Stafford as Chief Financial Officer - wahanariau.com
Zymeworks Names Kristin Stafford as New Chief Financial Officer - TipRanks
Zymeworks Appoints Kristin Stafford as Chief Financial Officer to Drive Strategic Growth and Value Creation - Minichart
Zymeworks appoints Kristin Stafford as chief financial officer - Investing.com
Kristin Stafford named Zymeworks executive VP and CFO as Kenneth Galbraith steps down as interim CFO - TradingView
Kristin Stafford joins Zymeworks (Nasdaq: ZYME) as new Chief Financial Officer - Stock Titan
How Investors May Respond To Zymeworks (ZYME) Fast Track Nod For Ovarian Cancer ADC ZW191 - Yahoo Finance
FDA grants fast track status to Zymeworks’ ZW191 for ovarian cancer By Investing.com - Investing.com South Africa
FDA grants fast track status to Zymeworks’ ZW191 for ovarian cancer - Investing.com Australia
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo - ACS Publications
Investment Report: Will Zymeworks Inc benefit from geopolitical trendsPrice Action & Target Return Focused Stock Picks - baoquankhu1.vn
Zymeworks Inc Receives U S Fda Fast Track Designation for Zw191 an Fra Targeting Antibody Drug Conjugate - marketscreener.com
Zymeworks Inc. (ZYME) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):